CLOs on the Move

Sarepta

www.sarepta.com

 
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare diseases. Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in Limb-girdle muscular dystrophy (LGMD), Charcot-Marie-Tooth (CMT) and CNS-related disorders, reaching a total of over 20 therapies in various stages of development. The Company`s programs span across several therapeutic modalities, including RNA, gene therapy and gene editing. Sarepta is poised to be the most meaningful precision genetic medicine company in the ...
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million
  • www.sarepta.com
  • 215 First Street
    Cambridge, MA USA 02142
  • Phone: 617.274.4000

Executives

Name Title Contact Details
Ryan Brown
 Interim General Counsel Profile
David Howton
 General Counsel Profile
David Pflugh
 Director, Patent Counsel Profile
Patrick O'Malley
 Executive Director, Regulatory Strategy Profile
Fubao Wang
 Vice President, Regulatory CMC Profile

Similar Companies

Parata Systems

Parata Systems is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Durham, NC. To find more information about Parata Systems, please visit www.parata.com

Vantage Holding Company

Vantage Holding Company is a Meadville, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CardioVention

CardioVention is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Pill Club

The Pill Club is the first all-in-one healthcare startup delivering and prescribing birth control across the US.

Cardiovascular Research Foundation

The Cardiovascular Research Foundation (CRF) in New York City is an independent, non-profit academic institution dedicated to improving the survival and quality of life of patients with cardiovascular disease through research and education.